Aurinia Pharm Ord (AUPH) Stock Price, Quote & News

Company Profile

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement wit...

Industry: Biotechnology

Sector: Healthcare

Phone: 250 744 2487

Fax: 250 708 4345

Website: www.auriniapharma.com

Address:

#140, 14315 – 118 Avenue, Edmonton, Canada

MoneyGroupLLC Dec. 7 at 7:21 AM

Enter: $AUPH Calls Strike Price: $16 Expiry Date: JAN 16 2026 Buy in Price: $0.85 - $1.10 Sell Price: $1.30 Profit : +53% (Turn every $1 into $1.53) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

LordDragon Dec. 7 at 3:39 AM

$AUPH 😎👋🏻💪🏻🙌🏻🤑 https://x.com/iamlorddragon/status/1997510826367062053?s=12&t=wZ0hXkLM-rfV7s8yGCT_SQ

0 · Reply

WallStreetBuyDip Dec. 7 at 1:14 AM

How do you make your trade? Will next trade $GME + $AUPH when H% is low. My summary for Small + Mid cap stocks. I ony buy when H% is low. The result speaks for itself. Got timestamps for the skeptics.

0 · Reply

Solomonwisdom7 Dec. 6 at 11:45 PM

$AUPH For allud longs…we made a great investment in a new company with a great drug for an unmet need. We have suffered all and every sort of BS in spite of our due diligence. Hopefully we are going to reap the rewards of our patience, diligence, and wisdom.

0 · Reply

F1318 Dec. 6 at 9:53 PM

$AUPH HODL folks...ignore the tree shaking and obvious price manipulation...shouldn't be long now. BO (not body odor) Lol

0 · Reply

BABYHAIR Dec. 6 at 7:22 PM

$AUPH Thought of the day concerning Tang Capital. Their weighted average is probably around $10 a share and they are likely up 60-80 mil on Auph. Why haven’t they sold any? After gains like that you’d usually see a little sell off just to rebalance the portfolio. I guess they are ok holding it as the third largest portion of their portfolio!

1 · Reply

QuarterlyTrader Dec. 6 at 4:14 PM

$AUPH hmmm. This feels like big boys did a stop loss attack just before something good happens. I have seen this recently at RIGL (a worthy chart example).

0 · Reply

jdoldnumber7 Dec. 6 at 12:55 PM

$AUPH I know drinking is my profession but did 61M shares really trade after-hours?

2 · Reply

F1318 Dec. 6 at 1:46 AM

$AUPH Ahh..the dip before the rip. Shake that tree lol.. hold on folks...

0 · Reply

Mooch99 Dec. 6 at 12:04 AM

$AUPH People actually buying after-hours today, a bit atypical.

1 · Reply

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?

Nov 4, 2025, 12:36 PM EST - 4 weeks ago

Aurinia Pharmaceuticals Inc. (AUPH) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 6:00 AM EST - 4 weeks ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

Nov 3, 2025, 7:31 AM EST - 4 weeks ago

Wall Street Breakfast Podcast: FDA Executive Controversy

Nov 3, 2025, 6:00 AM EST - 4 weeks ago

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

Oct 22, 2025, 11:20 PM EDT - 6 weeks ago

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating

Oct 15, 2025, 6:00 AM EDT - 7 weeks ago

Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025

Sep 29, 2025, 8:27 PM EDT - 2 months ago

Aurinia Responds to Now Retracted LinkedIn Post

Aug 6, 2025, 6:02 PM EDT - 4 months ago

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade)

Jul 31, 2025, 10:30 PM EDT - 4 months ago

Aurinia (AUPH) Q2 Revenue Jumps 22%

Jul 31, 2025, 5:57 PM EDT - 4 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 6:00 AM EDT - 4 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

Jul 22, 2025, 6:00 AM EDT - 4 months ago

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

Jul 7, 2025, 12:49 PM EDT - 5 months ago

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity

Jun 30, 2025, 6:00 AM EDT - 5 months ago

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

Jun 29, 2025, 5:00 PM EDT - 5 months ago

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

May 22, 2025, 6:00 AM EDT - 7 months ago

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

May 12, 2025, 12:56 PM EDT - 7 months ago

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

May 12, 2025, 11:04 AM EDT - 7 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript

May 12, 2025, 6:00 AM EDT - 7 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 5, 2025, 6:00 AM EDT - 7 months ago

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

Apr 30, 2025, 6:00 AM EDT - 7 months ago

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 29, 2025, 6:00 AM EDT - 7 months ago

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 26, 2025, 10:54 AM EDT - 8 months ago

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Apr 23, 2025, 4:05 PM EDT - 8 months ago

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting

Feb 27, 2025, 2:11 PM EST - 10 months ago

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Feb 27, 2025, 10:32 AM EST - 10 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:00 AM EST - 10 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

Feb 21, 2025, 4:09 PM EST - 10 months ago

Aurinia Pharmaceuticals: There's Still Time For Sales Growth

Feb 20, 2025, 4:05 PM EST - 10 months ago

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

Jan 22, 2025, 12:29 PM EST - 11 months ago

3 Biotech Stocks With Notable Insider Buying

AZN COGT JAZZ ONC XBI ZYME

Nov 18, 2024, 5:53 PM EST - 1 year ago

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Nov 15, 2024, 6:00 AM EST - 1 year ago

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

Aurinia to Participate in Jefferies London Healthcare Conference

Nov 8, 2024, 12:15 PM EST - 1 year ago

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon

Nov 7, 2024, 11:44 AM EST - 1 year ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:10 AM EST - 1 year ago

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Nov 7, 2024, 6:00 AM EST - 1 year ago

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

Oct 30, 2024, 4:05 PM EDT - 1 year ago

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

Oct 11, 2024, 6:00 AM EDT - 1 year ago

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

Sep 24, 2024, 8:10 AM EDT - 1 year ago

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

Sep 19, 2024, 12:54 PM EDT - 1 year ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

CORT VRDN

Sep 19, 2024, 7:55 AM EDT - 1 year ago

Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment

Sep 18, 2024, 4:41 AM EDT - 1 year ago

Aurinia Pharmaceuticals: This Recovery Can Continue

Sep 13, 2024, 6:00 AM EDT - 1 year ago

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 12, 2024, 4:05 PM EDT - 1 year ago

Aurinia Announces Board Restructuring

Sep 5, 2024, 6:00 AM EDT - 1 year ago

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Aug 28, 2024, 6:00 AM EDT - 1 year ago

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board

Aug 1, 2024, 1:52 PM EDT - 1 year ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q2 2024 Earnings Call Transcript

MoneyGroupLLC Dec. 7 at 7:21 AM

0 · Reply

LordDragon Dec. 7 at 3:39 AM

$AUPH 😎👋🏻💪🏻🙌🏻🤑 https://x.com/iamlorddragon/status/1997510826367062053?s=12&t=wZ0hXkLM-rfV7s8yGCT_SQ

0 · Reply

WallStreetBuyDip Dec. 7 at 1:14 AM

0 · Reply

Solomonwisdom7 Dec. 6 at 11:45 PM

0 · Reply

F1318 Dec. 6 at 9:53 PM

$AUPH HODL folks...ignore the tree shaking and obvious price manipulation...shouldn't be long now. BO (not body odor) Lol

0 · Reply

BABYHAIR Dec. 6 at 7:22 PM

1 · Reply

QuarterlyTrader Dec. 6 at 4:14 PM

$AUPH hmmm. This feels like big boys did a stop loss attack just before something good happens. I have seen this recently at RIGL (a worthy chart example).

0 · Reply

jdoldnumber7 Dec. 6 at 12:55 PM

$AUPH I know drinking is my profession but did 61M shares really trade after-hours?

2 · Reply

F1318 Dec. 6 at 1:46 AM

$AUPH Ahh..the dip before the rip. Shake that tree lol.. hold on folks...

0 · Reply

Mooch99 Dec. 6 at 12:04 AM

$AUPH People actually buying after-hours today, a bit atypical.

1 · Reply

BABYHAIR Dec. 5 at 10:21 PM

$AUPH I’d hate to be short going into the weekend - IBoesky

2 · Reply

ATzmansto Dec. 5 at 10:17 PM

$AUPH It could be a very interesting week coming up. Have a great weekend everyone.

0 · Reply

Send_IT_or_stepaside Dec. 5 at 9:37 PM

$AUPH so missed the boat there, was hoping for a drop into mid $14 range to pickup some extras, little gun shy having pig around

1 · Reply

ScottyK13 Dec. 5 at 9:36 PM

$AUPH don’t hold your breath as this is probably at least the 666 post we have had on a buyout weekend. Nothing personal and I hope you are right.

1 · Reply

d666d Dec. 5 at 9:22 PM

$AUPH hope that the BO talks this weekend adequately compensate longs and gets done this weekend as the last thing bidder needs is competition in the bidding.......

0 · Reply

ScottyK13 Dec. 5 at 9:20 PM

$AUPH very true but at least we got a nice close to the week.

0 · Reply

d666d Dec. 5 at 9:15 PM

$AUPH i am at a point once the institutional buys for the past month are in how the fuc!k can this be sitting at below 30 end of day based off the charts at end of aftermarket trades and I have not seen this bs in any other stock I follow..... if there is an example please feel free to supply so I can invest in them aswell.......

0 · Reply

BullIsBest Dec. 5 at 9:09 PM

$AUPH WTH, I stopped watching today since I have enough bad news in my life. Then the final check and Bam. Very Nice

0 · Reply

jdoldnumber7 Dec. 5 at 9:08 PM

$AUPH Fyi..... since quarter ended 5 weeks ago, this was our first down week!

0 · Reply

RedBarnCannabis Dec. 5 at 9:05 PM

$AUPH Well, that was a nice late afternoon erection.... woof! Just have to ignore the devious intraday manipulation. Just .88 away from new 52 week high.

0 · Reply

jdoldnumber7 Dec. 5 at 9:04 PM

$AUPH Damn, way more than what I expected today... Happy Trails 👣 until Monday!

0 · Reply

Auphiliate Dec. 5 at 8:55 PM

$AUPH Nobody believes!!! 🎅

1 · Reply

Market Cap	2.06B
Revenue (ttm)	235.13M
Net Income (ttm)	5.75M
EPS (ttm)	N/A
PE Ratio	23.92
Forward PE	19.75
Profit Margin	2.45%
Debt to Equity Ratio	0.00

Volume	1,495,900
Avg Vol	1,842,884
Day's Range	N/A - N/A
Shares Out	131.84M
Stochastic %K	52%
Beta	1.42
Analysts	Sell
Price Target	$16.71